HRT Financial’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,296
Closed -$929K 4209
2025
Q4
$929K Buy
38,296
+25,453
+198% +$618K ﹤0.01% 1769
2025
Q3
$312K Sell
12,843
-1,712
-12% -$41.5K ﹤0.01% 2144
2025
Q2
$353K Buy
+14,555
New +$351K ﹤0.01% 1773
2024
Q4
Sell
-10,725
Closed -$261K 2771
2024
Q3
$261K Buy
+10,725
New +$258K ﹤0.01% 1865

Other funds holding IBDS

HRT Financial's IBDS Position: Q1 2026 in Review

HRT Financial sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q1 2026, closing a stake of 38,296 shares — an estimated $929K sold.

HRT Financial first reported a position in IBDS in Q3 2024 and held it in 4 quarters. The position peaked at $929K in Q4 2025. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • HRT Financial reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 38,296 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $929K.
  • HRT Financial first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2024 and held it in 4 quarters.
  • HRT Financial's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $929K in Q4 2025.
  • 428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.